Tag Archives: technology

Political Drama Draws Alphabet-Owned Google Into Consumer Surveys

Google is using the interest surrounding the 2016 elections to vault more deeply into the political polling arena with its own polling service. Alphabet ( GOOGL ) subsidiary Google is offering its survey products to presidential and congressional campaigns — and getting them into newsrooms, according to  The Hill. Google collects its data through survey boxes that appear online before people can read a news article, as well as through an application for the Google Android operating system that provides credits to the Google Play store to people who answer questions, The Hill reported. The product is known as Google Consumer Surveys.  Nielsen Holdings ( NLSN ) also remains a major player in the survey industry. Online polling has long faced skepticism, however, since most Internet polls rely on self-selecting groups of respondents. Getting a representative sample including the elderly or poor, for example, can be difficult since they are less likely to have Internet access and would be excluded from sampling as a result. On the other hand, getting voters to participate in phone-based polling is becoming more difficult. The rate of people responding to phone surveys had already fallen to less than 10% in a 2012 Pew study , according to the Silicon Valley Business Journal. Google specifies that its sample is representative of the population on the Internet, according to the report. Google makes money from the surveys, but its data work also keeps the search company’s brand prominent in the political conversation. “As we started to get ready for the 2016 cycle, that’s when things really started to pick up a bit on my side,” Karen Sheldon, the Google account executive on the sales team for the product, said in The Hill’s report. The Wall Street Journal and the Washington Post have both used Google’s tools for political polling, and the company has struck a longer-term partnership with the Independent Journal Review, a right-leaning news website that has attracted attention for its viral videos starring presidential candidates, The Hill said. Other Silicon Valley companies focusing on political polling include SurveyMonkey, which The Hill said hired Mark Blumenthal, a well-respected pollster and writer, away from the Huffington Post in October. SurveyMonkey has a partnership with NBC News to produce polls for the 2016 election. Alphabet stock was up a fraction in early afternoon trading in the stock market today , near 764. Image provided by Shutterstock .

Here’s How Apple Could Up Its TV Game With Skinny Bundle On Hold

Loading the player… Apple ( AAPL ) has put plans for its own “skinny” streaming bundle on hold, but the tech giant could expand its presence in the television space with the acquisition of DVR maker TiVo ( TIVO ), according to an analyst with Albert Fried. Reports surfaced in late March that TiVo was in talks to be acquired by Rovi ( ROVI ), a supplier of interactive program guides. While the analyst says that deal has merits, a TiVo acquisition by a consumer electronics company like Apple, Amazon ( AMZN ) or Microsoft ( MSFT ) is more attractive. That’s because consumer electronics firms “can better market and develop TiVo and TiVo’s ability to sell to roughly 80 million (subscribers) could be better exploited.” TiVo shares jumped 23% on the buyout rumors to retake their downward-sloping 200-day line. The stock is now looking for support around that level, rising nearly 1% on the  stock market today . TiVo is trading 20% below its 52-week high. Apple tried to retake its 200-day line in Monday’s session, but closed the day just below that level. The stock has now fallen back below the 110 price level, edging up 0.4% intraday. Shares are trading about 18% below their all-time high reached at the end of last August. Amazon rose 1.8% intraday, while Microsoft ticked 0.4% higher. Meanwhile, Starz ( STRZA ) announced Tuesday it’s launching its own over-the-top streaming service, joining Netflix, Time Warner ( TWX )-owned HBO, CBS ( CBS ) and others in the pursuit of capturing the cord-cutting audience. The $8.99-a-month Starz service undercuts that of Netflix ( NFLX ), which is raising its price by $2 to $9.99 in May for “grandfathered in” customers. Starz rose fractionally while Netflix dipped 0.5%.

Allergan Touts Future Without Pfizer; Teva Deal Still On Track

The leadership of Allergan ( AGN ) moved to reassure investors Wednesday of the company’s bright future after its huge buyout by Pfizer ( PFE ) was canceled in the wake of new tax regulations. Allergan stock was up 3.5% in afternoon trading, near 245. On a conference call with analysts Wednesday morning, CEO Brenton Saunders maintained that the Treasury Department’s action against tax inversions  will have no impact on the stand-alone Allergan, which redomiciled to Ireland through an inversion deal with Warner Chilcott three years ago. The company will retain its 14% corporate tax rate, he said, and it should also be free to deploy capital however it chooses. Saunders also said Allergan’s $40 billion sale of its generic unit Actavis to Teva Pharmaceutical Industries ( TEVA ) is unaffected by the spiking of the Pfizer deal  and is on track to close in June. The timeline for that buyout was delayed from its original Q1 closing date, as Teva works its way through a multi-country regulatory clearance process, but Saunders said the two companies are determined to get it done. “Teva is doing a lot of work,” said Saunders. “They’ve restructured their company; they have named their entire leadership through a few levels that include 200 Allergan executives moving to Teva. … This is a great deal for Allergan, but also a great deal for Teva.” Teva stock was up almost 3% in afternoon trading on the stock market today , near 56. The closing of the Actavis sale should also give Allergan a big wad of cash, so many of the analysts’ questions on the call related to what it will do with the money. Several seemed to be rooting for share buybacks, given that Allergan stock is trading near a 52-week low in the wake of the Pfizer breakup. Saunders said all options are on the table, but he emphasized that Allergan’s “growth pharma” model means that it’s constantly on the hunt for growth assets. He said that Allergan’s business-development team has stayed active since the Pfizer deal was announced, and if the right opportunity came along “we could announce it tomorrow.” A couple of analysts raised the name of contact-lens giant Bausch & Lomb, with which Saunders has a personal history. He headed the company from 2010 until 2013, when it was sold to Valeant Pharmaceuticals International ( VRX ) for $8.7 billion. Given Valeant’s recent spectacular crackup , many on Wall Street have speculated that B&L might again go on sale, with Allergan a suitable buyer not only because of Saunders, but also because of Allergan’s large ophthalmology business. Saunders’ response to this seemed to be a swipe at Valeant’s infamously opaque financial reporting. “It sold for $8.7 billion four years ago, with a late-stage pipeline of 30-some programs, and a strong organic growth profile,” he said. “I can’t tell that any of those things today are still true. Based on public information, it’s impossible to tell that it’s worth more than it sold for four years ago.”